Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H42N8O3 |
| Molecular Weight | 562.7063 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CN=C3N)[C@H]4C[C@H](CCC5=NC6=C(N5)C=CC(=C6)C(C)(C)C)C4
InChI
InChIKey=LXFOLMYKSYSZQS-YKPYGOBTSA-N
InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(40)29(41-22)38-15-34-24-27(31)32-14-33-28(24)38)19-10-17(11-19)6-9-23-35-20-8-7-18(30(3,4)5)12-21(20)36-23/h7-8,12,14-17,19,22,25-26,29,39-40H,6,9-11,13H2,1-5H3,(H,35,36)(H2,31,32,33)/t17-,19-,22-,25-,26-,29-/m1/s1
| Molecular Formula | C30H42N8O3 |
| Molecular Weight | 562.7063 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://encrypted.google.com/patents/WO2014100662A1Curator's Comment: The description was created based on several sources, including
https://encrypted.google.com/patents/WO2012075381A1
Sources: https://encrypted.google.com/patents/WO2014100662A1
Curator's Comment: The description was created based on several sources, including
https://encrypted.google.com/patents/WO2012075381A1
Pinometostat, trans- (9H-Purin-6-amine, 9-[5-deoxy-5-[[trans-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methyl ethyl)amino]-β-D-ribofuranosyl]-) is an isomer of Pinometostat, a small molecule inhibitor of histone methyltransferase with potential antineoplastic activity. Pinometostat, trans-specifically blocks the activity of the histone lysine-methyltransferase DOT1L, thereby inhibiting the methylation of nucleosomal histone H3 on lysine 79 (H3K79) that is bound to the mixed lineage leukemia (MLL) fusion protein which targets genes and blocks the expression of leukemogenic genes.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1795117 Sources: https://encrypted.google.com/patents/WO2014100662A1 |
0.73 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://encrypted.google.com/patents/WO2014100662A1
Human leukemia cell line EOL-1 were used for activity evaluation. Exponentially growing EOL-1 cells were plated in 96-well plates at a density of 3×10^4 viable cells/well. Each treatment was seeded in triplicate with a final well volume of 150 μLs. Cells were incubated with increasing concentrations of DOT1L inhibitor up to 50 μΜ. Viable cell number was determined every 3 - 4 days for 11 days using the Guava Viacount assay (Millipore # 4000-0040) and analyzed on a Guava EasyCyte Plus instrument according to the manufacturer's protocol.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:58:01 GMT 2025
by
admin
on
Mon Mar 31 21:58:01 GMT 2025
|
| Record UNII |
F66X4M38G5
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
57345410
Created by
admin on Mon Mar 31 21:58:01 GMT 2025 , Edited by admin on Mon Mar 31 21:58:01 GMT 2025
|
PRIMARY | |||
|
1380288-88-9
Created by
admin on Mon Mar 31 21:58:01 GMT 2025 , Edited by admin on Mon Mar 31 21:58:01 GMT 2025
|
PRIMARY | |||
|
F66X4M38G5
Created by
admin on Mon Mar 31 21:58:01 GMT 2025 , Edited by admin on Mon Mar 31 21:58:01 GMT 2025
|
PRIMARY |